Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.73 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | CNR1 | P21554 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.51 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.51 |
| ▸ | NAMPT | P43490 | 1/20 | 0.50 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.50 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28426090 | 1.00 | ALDH1A1 (0.73) | ALDH1A1POLBSMN1; SMN2CA12MMP2 | |
| Hydrochloric Acid SCHEMBL8123779 | 0.98 | ALDH1A1 (0.71) | ALDH1A1POLBSMN1; SMN2CA12MMP2 | |
| SCHEMBL14619788 | 0.89 | ALDH1A1 (0.69) | ALDH1A1POLBCA12MMP2CA9 | |
| SCHEMBL20021998 | 0.89 | ALDH1A1 (0.69) | ALDH1A1POLBCA12MMP2CA9 | |
| SCHEMBL28868017 | 0.89 | ALDH1A1 (0.60) | ALDH1A1POLBSMN1; SMN2CA12MMP2 | |
| SCHEMBL28427228 | 0.89 | ALDH1A1 (0.60) | ALDH1A1POLBSMN1; SMN2CA12MMP2 | |
| SCHEMBL28423968 | 0.89 | ALDH1A1 (0.69) | ALDH1A1POLBCA12MMP2CA9 | |
| SCHEMBL29222859 | 0.89 | ALDH1A1 (0.60) | ALDH1A1POLBSMN1; SMN2CA12MMP2 | |
| SCHEMBL17923479 | 0.88 | ALDH1A1 (0.59) | ALDH1A1POLBSMN1; SMN2CA12MMP2 | |
| SCHEMBL11177625 | 0.88 | ALDH1A1 (0.59) | ALDH1A1POLBSMN1; SMN2CA12MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024164666-A1 | METHOD FOR PREPARING BENZYLAMINE DERIVATIVE BY VISIBLE LIGHT-PROMOTED NICKEL-CATALYZED AMINATION OF BENZYL C-H BONDS | 上海沃凯生物技术有限公司 | 2024-08-15 | — | — | WO | disclosed |
| CN-116063209-B | Method for preparing benzylamine derivative by catalyzing amination of benzyl C-H bond through nickel under promotion of visible light | 上海沃凯生物技术有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-116063209-A | Method for preparing benzylamine derivative by catalyzing amination of benzyl C-H bond through nickel under promotion of visible light | 上海沃凯生物技术有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-108976178-A | A kind of preparation method of chiral sulfonamide class organic compound | 云南民族大学 | 2018-12-11 | — | — | CN | disclosed |
| US-8426587-B2 | Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor | PHARMAXIS LTD. (AU) | 2013-04-23 | — | — | US | disclosed |
| US-20100298330-A1 | HALOALLYLAMINE INHIBITORS OF SSAO/VAP-1 AND USES THEREFOR | PHARMAXIS LTD. (AU) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298330-A1 | HALOALLYLAMINE INHIBITORS OF SSAO/VAP-1 AND USES THEREFOR | VAPA, SLC6A11, VAPB | ALDH1A1 118/4885POLB 1598/4885SMN1; SMN2 1608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.